David Ma, PhD
Co-Founder and CEO
David is responsible for establishing and executing corporate systems, business development, international collaboration, and the overall management of AMO. David’s prior positions include Manager of the Biotechnology Incubation Center at Academia Sinica, and Director of Business Development for Medigen Biotechnology Corp. David received his B.Sc. degree in Biochemistry and Molecular Biology from Purdue University (West Lafayette), and, in 2009, he obtained a Ph.D. in Biomedical Sciences at Washington University in St. Louis.
Sheng-Lung Huang, PhD
Co-Founder and CSO
Dr. Huang has worked on crystalline fiber based light sources and their application for 20 years. He invented a new method of high speed cellular-resolution optical coherence tomography for clinical use. He has served as the Chairman/Director of the Graduate Institute of Photonics and Optoelectronics, National Taiwan University and Chairman/Director of the Institute of Electro-Optical Engineering, National Sun Yat-Sen University and has been a guest professor at the Abbe School of Photonics, Friedrich-Schiller University of Jena, Germany. He was the Chairman of the IEEE Photonics Society Taipei Chapter and a steering board member of the European Master of Science in Photonics. Dr. Huang served as a Topical Editor of Optics Letters for 6 years and as Guest Editor for Taiwan Photonics Society Quarterly. He was the recipient of a Ministry of Education Outstanding University/Industry Cooperation Award, 1997, and he and his students have together won several awards, including the Chimei Innovation Excellence Award (2010) and the Optical Communications Elite Award (2005). Dr. Huang received his B.Sc. degree from the Department of Electrical Engineering, National Taiwan University, and his M.Sc. and Ph.D. degrees from the Department of Electrical Engineering, University of Maryland, College Park.
Chih-Wei Lu, PhD
Co-Founder and CTO
He is dedicated to the development of biomedical optics, specializing in optical coherence tomography (OCT). He received his Ph.D. from the Graduate Institute of Photonics and Optoelectronics, National Taiwan University and has published more than 50 journal and international conference papers on OCT. He has served in the Biomedical Technology and Device Research Labs (BDL), the Industrial Technology Research Institute (ITRI) and the Biomedical Engineer Research and Development Center, National Yang Ming University. He has led several projects on the development of electro-optical medical devices and is familiar with the commercialization of medical devices.
Jason Liang, PhD, JD
Co-Founder and V.P.
Chang-Hsing Liang has a technology background in chemistry and life science. Before Dr. Liang joined AMO, he worked for several international law firms focusing on helping start-up companies with their IP strategies development and patent portfolio management.
Emily Tsai, PhD
Emily joined AMO in 2018 and is responsible for managing international clinical research and supporting operational aspects of clinical studies. Emily Tsai received her PhD in Molecular and Cellular Biology from the University of Pittsburgh. She completed a post-doctoral fellowship at Johns Hopkins University School of Medicine focused on cancer biology. Her past positions include Product Manager at medical device startup company BRAXX and Scientist at Impax Laboratories.